drugset

drugset / Trial / NCT06516068

A Trial of HRS-1893 in Patients With Obstructive Hypertrophic Cardiomyopathy

NCT06516068 ↗

Phase 2 Active not recruiting 42 enrolled Shandong Suncadia Medicine Co., Ltd.

NaSingle-groupOpen-labelTreatment

Summary

The study is being conducted to evaluate the efficacy, and safety of HRS-1893 for obstructive hypertrophic cardiomyopathy

Timeline

Start: 2024-08-11
Primary completion: 2024-11-18
Completion: 2025-08

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	HRS-1893	Unknown	—	—

Indications